ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

TUESDAY 24 APRIL 2018

11:25 > Development of quality in CBCT: How we can get the best from the system Speaker: J. Bissonnette (Canada)

SP-0688

11:50 > CBCT QA: European guidelines by EFOMP-ESTRO-IAEA Speaker: A. Torresin (Italy)

SP-0689

SYMPOSIUM Dose painting – from bench to bed(?) 11:00 - 12:15  |  ROOM 115 Chair: T. Nyholm (Sweden) Co-Chair: C. Stokkevåg (Norway)

11:00 > Tracer development: principle and clinical implementation Speaker: U. Haberkorn (Germany)

SP-0690

11:18 > From beds to prescription – dose painting numbers from conventional RT outcome and pre-treatment data Speaker: A. Ahnesjö (Sweden) 11:36 > From prescription to delivery - optimisation, robustness and quality assurance Speaker: E. Sterpin (Belgium)

SP-0691

SP-0692

11:54 > Dose painting: conclusions from clinical trials Speaker: W. De Neve (Belgium)

SP-0693

DEBATE Autoplanning, is there still a bright future for RTTs after automation? 11:00 - 12:15  |  ROOM 129-130 Autoplanning can play a role to improve plan quality and consistency, by making it possible to explore more treatment options than would be possible in everyday routine. It can increase the efficiency as well. Several planning studies show that autoplanning offers good class solutions. Furthermore, with autoplanning, RTT’s can focus on other parts of the planning process, e.g. the development of techniques. However, several drawbacks can be defined using autoplanning. The risk of RTT’s not being able to make a treatment plan manually is one of them. In this debate the future for RTTs when using autoplanning will be discussed. Chair: M. Mast (The Netherlands) Co-Chair: S. Mercieca (Malta)

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

185